Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
38 /100
MEDIUM RISK
Score updated Aug 28, 2026

NVAX — Novavax, Inc. Dilution Risk Tracker

Track NVAX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NVAX — Get alerts when the score changes →

As of August 28, 2026, Novavax, Inc. (NVAX) has a DilutionWatch DilutionScore of 38/100, rated MEDIUM dilution risk. Novavax, Inc. has a market capitalization of $1.80B, 164.95M shares outstanding, 262 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
40
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄 Convertible Debt
35

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
🔁 Convertible Conversion model 15%
• Convertible debt present: 13.5% potential dilution
🔔 Track NVAX — Get forecast alerts →

Market Data

Market Cap$1.80B
Shares Outstanding164.95M
Float141.47M
Cash$719.34M
Debt$291.88M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 11.3% shares (2026Q1 vs prior)
262 institutional holders · 150.69M shares
#1 SHAH CAPITAL MANAGEMENT 14.85M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 14.26M shares
#3 BlackRock, Inc. 12.84M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest45.66M
Days to Cover16.6
% of Float32.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual NVAX Dilution Snapshot

Novavax, Inc. (NVAX) has a DilutionScore of 38/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track NVAX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NVAX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NVAX
NVAX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.